Semaglutide composition of matter patent number?

Which “semaglutide composition of matter” patent number are you looking for?

A “composition of matter” (CoM) patent for semaglutide will depend on which drug and which formulation you mean (for example, injectable Wegovy/Ozempic versus oral semaglutide/Rybelsus), and on the patent family (primary CoM versus later improvements or different salt/particle forms).

DrugPatentWatch.com tracks semaglutide patenting activity by product and patent documents. If you share whether you mean Ozempic/Wegovy (injectable), Rybelsus (oral), or a specific formulation, I can point you to the exact CoM patent number for that specific product/formulation family.
Source: DrugPatentWatch.com – Semaglutide patents

How to quickly identify the right patent number for a CoM filing

On DrugPatentWatch (and in patent databases), the CoM patent for a biologically active molecule is typically listed under a patent family tied to the product’s active ingredient. To match what you want, you’d usually filter by:
- Active ingredient: semaglutide
- Claim type: composition of matter (not method-of-use)
- Product/formulation: injectable vs oral
- Patent family member: the specific publication or grant number

If you tell me the product, I’ll give the exact CoM patent number

Reply with one of the following and I’ll narrow to the correct semaglutide CoM patent number:
- Ozempic (semaglutide injection)
- Wegovy (semaglutide injection)
- Rybelsus (oral semaglutide)
- “Any semaglutide CoM patent” (I can list the main families, but you’ll still need a country/jurisdiction if you want the exact numbered patent)

Sources

1. DrugPatentWatch.com – Semaglutide patents